Puma Biotechnology Sees FY2025 Sales $212.000M-$222.000M vs $207.90M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Puma Biotechnology (NASDAQ:PBYI) sees FY2025 sales of $212.000 million-$222.000 million vs $207.90 million analyst estimate.
Puma Biotechnology (NASDAQ:PBYI) sees FY2025 sales of $212.000 million-$222.000 million vs $207.90 million analyst estimate.